Healthy Extracts (HYEX) AI Stock Analysis

• Market Cap: $7.14M
• Dividend Yield: N/A
• Average Volume (3M): 170.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.45
• Revenue Growth: 25.24%
• EPS Growth: 66.44%
• Country: US
• Employees: 4
• Sector: Healthcare
• Sector Strength: 77
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.29
• Shares Outstanding: 2,989,406
• 10 Day Avg. Volume: 270
• 30 Day Avg. Volume: 170
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 1.25
• Price to Cash Flow (P/CF): 18.00
• P/FCF Ratio: 10.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Healthy Extracts has shown potential in revenue growth, but the persistent profitability issues and high financial leverage are significant risks. Technical indicators suggest short-term momentum, but valuation concerns stemming from negative earnings and no dividend yield weigh heavily on the stock's appeal. The overall score reflects these mixed signals, indicating caution for investors.

Healthy Extracts Business Overview & Revenue Model

Company Description

Healthy Extracts (HYEX) is a company focused on developing and marketing plant-based products for health and wellness. The company operates in the nutraceutical sector, offering a range of products that aim to support cognitive function, heart health, and overall well-being. Their core products include proprietary formulations derived from natural ingredients, designed to enhance physical and mental performance.

How the Company Makes Money

Healthy Extracts makes money primarily through the sale of its nutraceutical products. The company generates revenue by selling directly to consumers through its e-commerce platform and by distributing its products through various retail and online channels. Key revenue streams include the sales of their branded supplements and custom formulations. The company also benefits from strategic partnerships with other health and wellness brands, which help expand its distribution network and increase product visibility. Additionally, Healthy Extracts may engage in licensing agreements for their proprietary formulations, providing another revenue source.

Healthy Extracts Financial Statement Overview

Summary

Healthy Extracts shows a mixed performance. Revenue growth is notable, but profitability margins are negative. The balance sheet is moderately leveraged with a Debt-to-Equity Ratio of 1.15, and cash flow management is improving. However, high leverage and negative equity returns pose risks.

Income Statement

Healthy Extracts shows a mixed performance in terms of profitability and growth. Although there is a notable revenue growth from the previous year, the company struggles with negative profitability margins. The Gross Profit Margin is 68.5% for TTM, which is robust, but the Net Profit Margin remains negative at -25.6%. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies and high costs impacting earnings.

Balance Sheet

The balance sheet indicates a moderately leveraged position, with a Debt-to-Equity Ratio of 1.15. While the Equity Ratio stands at 32.5%, showcasing some stability, the Return on Equity is negative due to persistent losses. The company’s financial structure suggests a need for improved equity base and debt management.

Cash Flow

The cash flow analysis reveals improvement in operating cash flow, turning positive in the TTM at $295,713. The Free Cash Flow to Net Income ratio is negative due to net losses, but the Operating Cash Flow to Net Income ratio is positive, indicating some cash profitability despite overall losses. The Free Cash Flow Growth Rate is strong, highlighting better cash management.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
3.01M	2.49M	2.25M	1.47M	1.28M	748.38K
	Gross Profit
2.06M	1.62M	1.37M	695.08K	-578.44K	223.88K
	EBIT
-310.58K	-2.24M	-904.75K	-1.89M	-2.05M	-939.86K
	EBITDA
-891.75K	-2.24M	-910.71K	-1.89M	-2.49M	-923.33K
	Net Income Common Stockholders
-771.91K	-2.47M	-989.96K	-2.04M	-2.65M	632.78K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.54K	19.44K	65.65K	222.10K	59.20K	133.45K
	Total Assets
155.12K	2.64M	2.78M	3.03M	3.12M	3.45M
	Total Debt
0.00	1.13M	593.52K	342.62K	177.62K	2.64M
	Net Debt
-1.54K	1.11M	527.87K	120.52K	118.42K	2.51M
	Total Liabilities
25.15K	1.68M	902.79K	558.84K	261.61K	4.32M
	Stockholders Equity
129.97K	954.59K	1.88M	2.47M	2.85M	-865.61K
Cash Flow		Free Cash Flow
295.71K	-415.75K	-342.95K	-997.30K	-3.49M	-3.51M
	Operating Cash Flow
295.71K	-415.75K	-334.96K	-901.30K	-3.48M	-3.49M
	Investing Cash Flow
0.00	0.00	-7.99K	-96.00K	-425.88K	1.81M
	Financing Cash Flow
-241.70K	369.54K	239.52K	1.16M	3.83M	1.81M

Healthy Extracts Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.39
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYEX, the sentiment is Positive. The current price of 2.39 is above the 20-day moving average (MA) of 1.68, above the 50-day MA of 1.63, and below the 200-day MA of 2.57, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 68.07 is Neutral, neither overbought nor oversold. The STOCH value of 99.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HYEX.

Healthy Extracts Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HYEX	49 Neutral	$7.14M	―	-123.11%	―	25.24%	66.44%
Sector *	48 Neutral	$6.36B	1.14	-49.01%	2.63%	17.12%	1.49%
HSDT	39 Underperform	$2.39M	―	-688.88%	―	-19.25%	59.74%
APDN	37 Underperform	$1.60M	―	-100.40%	―	-58.46%	47.98%
CVSI	37 Underperform	$5.56M	―	-101.92%	―	-1.87%	-165.87%